TP53 and neoplasm: Consistent with these studies, we observed the ability of the p53125–134/HLA-A24-specific P1C1TM antibody to specifically deliver the DNA-targeted cytotoxic drugs PDB and PNU-159682, to inhibit mutant p53+ tumour cell growth in vitro.